Managing first-line failure

por Cooper, David A
Publicado 2014

In memoriam: Joep Lange MD, PhD

por Beyrer, Chris, Vella, Stefano, Cooper, David A.
Publicado 2014

Predictors of disease progression in HIV infection: a review

por Langford, Simone E, Ananworanich, Jintanat, Cooper, David A
Publicado 2007

HIV research in Australia: linking basic research findings with clinical and public health outcomes

por Lewin, Sharon R, Kaldor, John M, Cooper, David A
Publicado 2006

Explaining the Determinants of First Phase HIV Decay Dynamics through the Effects of Stage-dependent Drug Action

por Gilmore, James B., Kelleher, Anthony D., Cooper, David A., Murray, John M.
Publicado 2013

Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine

por Martin, Allison, Amin, Janaki, Emery, Sean, Baker, David, Carr, Andrew, Cooper, David A., Bloch, Mark
Publicado 2011

HLA Alleles Association with Changes in Bone Mineral Density in HIV-1-Infected Adults Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine

por Haskelberg, Hila, Cordery, Damien V., Amin, Janaki, Kelleher, Anthony D., Cooper, David A., Emery, Sean
Publicado 2014

Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells

por Ahlenstiel, Chantelle L., Lim, Heidi G. W., Cooper, David A., Ishida, Takaomi, Kelleher, Anthony D., Suzuki, Kazuo
Publicado 2012

Closed Chromatin Architecture Is Induced by an RNA Duplex Targeting the HIV-1 Promoter Region

por Suzuki, Kazuo, Juelich, Torsten, Lim, Heidi, Ishida, Takaomi, Watanebe, Toshiki, Cooper, David A., Rao, Sudha, Kelleher, Anthony D.
Publicado 2008

Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial

por Achhra, Amit C., Boyd, Mark A., Law, Matthew G., Matthews, Gail V., Kelleher, Anthony D., Cooper, David A.
Publicado 2014

The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa

por Schneider, Karen, Nwizu, Chidi, Kaplan, Richard, Anderson, Jonathan, Wilson, David P., Emery, Sean, Cooper, David A., Boyd, Mark A.
Publicado 2013

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing

por Ahlenstiel, Chantelle, Mendez, Catalina, Lim, Steven T H, Marks, Katherine, Turville, Stuart, Cooper, David A, Kelleher, Anthony D, Suzuki, Kazuo
Publicado 2015

Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia

por Hoare, Alexander, Kerr, Stephen J., Ruxrungtham, Kiat, Ananworanich, Jintanat, Law, Matthew G., Cooper, David A., Phanuphak, Praphan, Wilson, David P.
Publicado 2010

The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53

por Reuland, Steven N., Goldstein, Nathaniel B., Partyka, Katie A., Cooper, David A., Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.
Publicado 2011

HIV dynamics linked to memory CD4+ T cell homeostasis

por Murray, John M., Zaunders, John, Emery, Sean, Cooper, David A., Hey-Nguyen, William J., Koelsch, Kersten K., Kelleher, Anthony D.
Publicado 2017

Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok

por Clarke, Amanda, Kerr, Stephen, Honeybrook, Adam, Cooper, David A, Avihingsanon, Anchalee, Duncombe, Chris, Phanuphak, Praphan, Ruxrungtham, Kiat, Ananworanich, Jintanat, Kaldor, John
Publicado 2012

Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia

por Wright, Stephen T, Law, Matthew G, Cooper, David A, Keen, Phillip, McDonald, Ann, Middleton, Melanie, Woolley, Ian, Kelly, Mark, Petoumenos, Kathy
Publicado 2015

Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years—The Australian Positive & Peers Longevity Evaluation Study (APPLE...

por Petoumenos, Kathy, Huang, Robin, Hoy, Jennifer, Bloch, Mark, Templeton, David J., Baker, David, Giles, Michelle, Law, Matthew G., Cooper, David A.
Publicado 2017

Switching Virally Suppressed, Treatment-Experienced Patients to a Raltegravir-Containing Regimen Does Not Alter Levels of HIV-1 DNA

por Lam, Yu Ming Paul, McBride, Kristin L., Amin, Janaki, Cordery, Damien V., Kelleher, Anthony D., Cooper, David A., Koelsch, Kersten K.
Publicado 2012

HIV care in Yangon, Myanmar; successes, challenges and implications for policy

por Aung, Ne Myo, Hanson, Josh, Kyi, Tint Tint, Htet, Zaw Win, Cooper, David A., Boyd, Mark A., Kyi, Mar Mar, Saw, Htin Aung
Publicado 2017